Publications by authors named "D P Mawer"

This multi-arm, parallel group, single-blinded randomised controlled trial aimed to assess three commercially available mouthwashes effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This manuscript has been written in accordance with the CONSORT statement. Eligible participants were SARS-CoV-2 positive with a positive test in the last 72 h.

View Article and Find Full Text PDF

Importance: Staphylococcus aureus surgical site infections (SSIs) and bloodstream infections (BSIs) are important complications of surgical procedures for which prevention remains suboptimal. Contemporary data on the incidence of and etiologic factors for these infections are needed to support the development of improved preventive strategies.

Objectives: To assess the occurrence of postoperative S aureus SSIs and BSIs and quantify its association with patient-related and contextual factors.

View Article and Find Full Text PDF

Summary: Mpox (MPX) formerly known as monkeypox was declared a public health emergency of international concern, following an outbreak that commenced in May 2022. We report a case of subacute thyroiditis following MPX infection. To our knowledge, it is the first documented incidence of this complication in humans.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to assess a comprehensive behavior change intervention aimed at reducing unnecessary antibiotic use in hospitals by encouraging prescribers to make appropriate decisions during clinical reviews.
  • The research utilized a randomized controlled trial across multiple hospitals in the UK, tracking outcomes such as antibiotic dosage and patient mortality within 30 days post-admission through electronic health records and audits.
  • The effectiveness of the intervention was analyzed using time series methods and random-effects meta-analysis, with the study now completed and registered for validation.
View Article and Find Full Text PDF

Fosfomycin has retained activity against many multi-drug resistant (MDR) Gram-negatives, and may be useful against extended spectrum beta-lactamase (ESBL) producing and carbapenem-resistant Enterobacterales to improve clinical outcomes. There are few data from the UK on the susceptibility of invasive Gram-negative isolates to fosfomycin, especially in the era of increasing use of oral fosfomycin for urinary tract infections (UTIs). We evaluated fosfomycin susceptibility against 100 consecutive Gram-negative bloodstream isolates, both individually, and in combination with other mechanistically similar and differing antibiotics.

View Article and Find Full Text PDF